Loading data
PTHSNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 16.8 m USD | 0 USD | — | — |
| Cost of revenue | 3.99 m USD | 0 USD | — | — |
| Research and development expense | 1.23 m USD | 1.18 m USD | 2.58 m USD | 391.73 k USD |
| Selling, general and administrative expense | 42.45 m USD | 6.39 m USD | — | — |
| Operating profit | -32.43 m USD | -7.57 m USD | -6.86 m USD | -2.32 m USD |
| Profit before tax | -50.71 m USD | -7.96 m USD | — | — |
| Income tax expense | -7.39 m USD | 0 USD | — | — |
| Net income (reported basis) | -43.32 m USD | -7.96 m USD | -7.38 m USD | -2.46 m USD |
| Basic earnings per share | -23.04 USD/share | -14.27 USD/share | -5.78 USD/share | — |
| Diluted earnings per share | -23.04 USD/share | -14.27 USD/share | -5.78 USD/share | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.